Results 121 to 130 of about 41,654 (227)
Survival and Prognostic Factors of 215 Post‐Transplant Lymphoproliferative Disorders After Solid Organ Transplantations in a Finnish Nationwide Population‐Based Study Over 30 Years
Hematological Oncology, Volume 44, Issue 2, March 2026.ABSTRACT
Post‐transplant lymphoproliferative disorder (PTLD) is a rare, dreaded complication of organ transplantation with major clinical challenges. We conducted a nationwide population‐based study of all solid organ transplant (SOT) recipients (n = 6555), both adults and children, over a 30‐year period in Finland.Terhi K. Friman, Birgitta Salmela, Ilkka Helanterä, Fredrik Åberg, Timo Jahnukainen, Maija Halme, Samuli Vaittinen, Jyri Lommi, Markku O. Pentikäinen, Panu E. Kovanen, Sirpa Leppä, Riikka Räty +11 morewiley +1 more sourceRNA‐Based Therapies for Inherited Metabolic Disorders
Journal of Inherited Metabolic Disease, Volume 49, Issue 2, March 2026.ABSTRACT
Inherited metabolic disorders (IMDs) are a diverse and complex group of genetic conditions resulting from deficiencies in enzymes, transporters, or cofactors. These deficiencies lead to metabolic dysfunction and severe clinical consequences. Despite significant progress in understanding their molecular basis, treatment options remain limited ...Reddy Sreekanth Vootukuri, Sonam Gurung, Roopkatha Ghosh, Philippa B. Mills, Julien Baruteau, Haiyan Zhou +5 morewiley +1 more sourceHuman Cyclophilins—An Emerging Class of Drug Targets
Medicinal Research Reviews, Volume 46, Issue 2, Page 475-512, March 2026.ABSTRACT
Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...Katarina Jurkova, Hana Navratilova, Kamil Musilek, Ondrej Benek +3 morewiley +1 more sourceMesoporous Materials for Electrochemical Biosensors: From Broad Structure to Silica Film
Small, Volume 22, Issue 13, 3 March 2026.This review showcases how mesoporous materials advance biosensing, spanning from material classes and fabrication strategies to the unique role of silica films as functional sensing platforms. With tunable porosity, high surface area, and versatile chemistry, these materials enhance selectivity and signal amplification in biosensors.Vinh Khanh Ho, Tuan‐Khoa Nguyen, Sina Jamali, Nam‐Trung Nguyen +3 morewiley +1 more sourceThickness Calculation of Pigment Layers and Gold Leaves Using XRF and MA‐XRF Data
X-Ray Spectrometry, Volume 55, Issue 2, Page 335-348, March/April 2026.ABSTRACT
In this work, XRF and MA‐XRF data were used to estimate the thickness of Chromium Oxide (Cr₂O₃) pigment and gold leaf applied over Lead White (2PbCO3.Pb(OH)2). The thickness determination was based on the differential attenuation of the Pb‐Lα and Pb‐Lβ characteristic X‐rays, which allows correlating the overlying material layer with the Pb(Lα ...Renato Pereira de Freitas, Ana Letícia Castro de Oliveira, André Rocha Pimenta, Elicardo Alves de Souza Gonçalves, Valter de Souza Felix, Marcelo Oliveira Pereira, Leandro Oliveira Pereira, Rafael Barreto Almada, Raysa Costa Nardes, Marcelino dos Anjos +9 morewiley +1 more sourceTransmission of Renormalized Benzene Circuits
, 2015 The renormalization equations emerge from a Greenian-matrix solution of the
discretized Schrodinger equation. A by-product of these equations is the
decimation process, which enables substituted-benzenes to be mapped onto
corresponding dimers, that are ...Davison, Sydney G., Sulston, Kenneth W.core Metals' Adsorption Onto Environmental Microplastics at Shoreline Sediments
X-Ray Spectrometry, Volume 55, Issue 2, Page 349-365, March/April 2026.ABSTRACT
This study assessed trace element concentrations and microplastic (MP) contamination in three sandy beaches on the southern coast of Ilha Grande (Rio de Janeiro, Brazil). Environmental MPs were manually extracted from sand samples, and beaches were classified using the microplastic pollution index (MPPI).Adriana F. Curty, Fábio Tsuyama, Priscilla M. O. M. Cunha, Marcelino J. Anjos, André L. S. Salomão +4 morewiley +1 more sourceTechniques to Detect and Quantify the Bacterial Metalloprotease AprX in Bovine Milk: A Review
Comprehensive Reviews in Food Science and Food Safety, Volume 25, Issue 2, March 2026.ABSTRACT
The heat‐stable metalloprotease AprX, secreted by psychrotrophic Pseudomonas spp., is a major cause of quality deterioration in dairy products, particularly ultrahigh temperature (UHT) milk. This review synthesizes the evolution and current state of detection and quantification techniques for AprX in bovine milk, covering traditional ...Aritra Sinha, Alan L. Kellywiley +1 more sourcePrognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG‐MM5 Trial
European Journal of Haematology, Volume 116, Issue 3, Page 226-234, March 2026.ABSTRACT
Response assessment during treatment of multiple myeloma (MM) typically relies on immunofixation and serum electrophoresis. However, low levels of IgG and especially IgA paraprotein are difficult to quantify reliably. The Hevylite Assay quantifies the kappa and lambda fractions of IgG and IgA separately and is useful to determine response to ...Tim Richardson, Elias Mai, Ekaterina Menis, Axel Benner, Diana Tichy, Kaya Miah, Mathias Hänel, Britta Besemer, Amelie Boquoi, Igor Wolfgang Blau, Christian S. Michel, Hans Walter Lindemann, Snjezana Janjetovic, Peter Brossart, Helga Bernhard, Peter Reimer, Hans Salwender, Dirk Hose, Anja Seckinger, Marc Raab, Hartmut Goldschmidt, Christof Scheid, For the German‐Speaking Myeloma Multicenter Group (GMMG) HD5 Investigators, Koordinierungszentrum für Klinische Studien, KKS) Heidelberg, Facharztpraxis Hämatologie und Onkologie, Praxisnetzwerk Hämatologie/Internistische Onkologie, Facharztpraxis Onkologie, Caritas Krankenhaus Bad Mergentheim, MVZ Baden‐Baden, Charité Universitätsmedizin Berlin, Charité Universitätsmedizin Berlin, HELIOS Klinikum Berlin‐Buch, Medizinisches Versorgungszentrum, Facharztpraxis Onkologie, Onkologie Seestrasse, Klinikum Bielefeld Mitte, Facharztpraxis Onkologie, Universitätsklinikum Bonn, Johanniter Krankenhaus Bonn, Onkologie Rheinsieg, Städt. Klinikum Braunschweig, Onkologische Schwerpunktpraxis, Onkologische Praxis im Krankenhaus Buchholz, Onkologische Schwerpunktpraxis, Klinikum Chemnitz, Regiomed Kliniken GmbH, Carl‐Thiem‐Klinikum Cottbus, Klinikum Darmstadt, Onkologische Schwerpunktpraxis, Gemeinschaftspraxis für Hämatologie und Onkologie, Fachpraxis für Hämatologie und Onkologie, Universitätsklinikum Essen, Evangelisches Krankenhaus Essen‐Werden Zentrum für Innere Medizin, Universitätsklinikum Frankfurt, Agaplesion Medizinisches Versorgungszentrum, MVZ) Frankfurt, Krankenhaus Nordwest, Interdisziplinäres Facharztzentrum, IFS) Frankfurt, Vitanus GmbH, Frankfurter Rotkreuz‐Kliniken, PIOH‐Praxis für Internistische Onkologie und Hämatologie, Onkologische Facharztpraxis, Facharztpraxis für Hämatologie und Onkologie, Kath. Krankenhaus Hagen, Asklepios Klinik Altona, Asklepios Klinik St. Georg, Hämatologisch‐Onkologische Praxis Altona, Facharztpraxis für Hämatologie und Onkologie, OncoResearch Lerchenfeld UG, Evangelisches Krankenhaus Hamm gGmbH, Onkologische Schwerpunktpraxis, Klinikum Hanau GmbH, Klinikum Region Hannover, Onkologisches Ambulanzzentrum OAZ Hannover, Universitätsklinikum Heidelberg, Onkologische Schwerpunktpraxis, Onkologische Schwerpunktpraxis Heilbronn, SLK Kliniken Heilbronn GmbH, Facharztpraxis für Hämatologie und Tumorerkrankungen, Universitätsklinikum des Saarlandes, Klinikum Idar‐Oberstein, Schwerpunktpraxis für Hämatologie und Onkologie, Gemeinschaftspraxis für Hämatologie, Universitätsklinikum Köln, Onkologie Köln, Praxis Internistischer Onkologie und Hämatologie, Kliniken Köln, Facharztpraxis für Hämatologie, Onkologisches Zentrum Lebach, Klinikum der Stadt Ludwigshafen am Rhein, Onkologische Schwerpunktpraxis Lüneburg, Universitätsmedizin der Johannes Gutenberg‐Universität Mainz, MED Facharztzentrum, Universitätsmedizin Mannheim, Mannheimer Onkologie Praxis, Facharztpraxis für Innere Medizin, Praxis für Innere Medizin, AöR) Johannes Wesling Klinikum Minden, Kliniken Maria Hilf, Städtisches Klinikum München, Facharztpraxis für Innere Medizin, medius Kliniken, Onkologische Facharztpraxis, Paracelsus Kliniken, medius Kliniken, Medizinisches Versorgungszentrum am Siloah St. Trudbert‐Klinikum, Onkologische Praxis Pinneberg, Gemeinschaftspraxis Innere Medizin/Onkologie, Facharztpraxis für Onkologie, Diakonie‐Klinikum Schwäbisch Hall, Zaho‐Zentrum für ambulante Hämatologie und Onkologie, Diakonie Klinikum Jung‐Stilling, Gastroenterologie Onkologie Bodensee, Onkologische Schwerpunktpraxis Speyer, Marienhospital Stuttgart, Krankenhaus der Barmherzigen Brüder Trier, Klinikum Mutterhaus der Borromäerinnen Trier, Onkologische Schwerpunktpraxis am Brüderkrankenhaus Trier, Onkologie Rheinsieg, Universität Tübingen, OMM Optimed Mundial GmbH, Facharztpraxis für Onkologie, Ammerland Klinik, Facharztpraxis für Onkologie +125 morewiley +1 more source